Hong Kong-based Dragon Jade International Limited says it is negotiating for the exclusive licensing rights to SleepMate, a medical monitoring application device.
The alliance, upon completion, will cover two major strategic initiatives:
1. Food and Drug Administration Approval
Parties will collaborate on submitting a medical device submission for FDA clearance on the SleepMate product. The SleepMate device is categorized as a “lowest risk” device according to the FDA guidelines and can be submitted under a FDA fast-track process, Dragon Jade says.
2. Exclusive Distribution of SleepMate Products
Dragon Jade will be granted an exclusive license to represent and distribute all SleepMate products. The company will leverage its proprietary medicinal resellers network to capitalize on marketing the FDA-approved SleepMate brand.
SleepMate was developed and manufactured by a Chinese technology company for the Chinese market. The initial product is a blanket with sensors placed within it. The sensors monitor heart rate, respiration rate, sleep quality, and depth. Data collected can be transmitted to smartphones or computers through Bluetooth and WiFi.
